CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 123 filers reported holding CLOVIS ONCOLOGY INC in Q2 2016. The put-call ratio across all filers is 1.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $207,000 | -21.3% | 8,375 | -6.4% | 0.00% | -50.0% |
| Q3 2018 | $263,000 | -46.9% | 8,945 | -18.5% | 0.00% | -50.0% |
| Q2 2018 | $495,000 | +121.0% | 10,970 | +38.9% | 0.00% | +100.0% |
| Q1 2018 | $224,000 | +12.0% | 7,897 | +119.9% | 0.00% | 0.0% |
| Q3 2017 | $200,000 | -47.1% | 3,591 | -27.1% | 0.00% | -33.3% |
| Q2 2017 | $378,000 | -36.8% | 4,929 | -70.4% | 0.00% | -57.1% |
| Q3 2016 | $598,000 | +200.5% | 16,625 | +59.5% | 0.01% | +600.0% |
| Q1 2016 | $199,000 | -31.8% | 10,425 | +25.6% | 0.00% | -66.7% |
| Q4 2015 | $292,000 | -29.6% | 8,300 | +84.2% | 0.00% | -40.0% |
| Q3 2015 | $415,000 | +38.3% | 4,507 | +32.3% | 0.01% | 0.0% |
| Q2 2015 | $300,000 | – | 3,407 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,402,781 | $231,389,000 | 9.96% |
| Versant Venture Management, LLC | 101,855 | $6,926,140,000 | 7.29% |
| Avoro Capital Advisors LLC | 1,102,884 | $74,996,000 | 4.86% |
| Redmile Group, LLC | 1,320,027 | $89,762,000 | 3.90% |
| NEXTHERA CAPITAL LP | 233,200 | $15,858,000 | 2.92% |
| Iguana Healthcare Management, LLC | 60,000 | $4,080,000 | 2.66% |
| HealthCor Management, L.P. | 973,840 | $66,221,000 | 2.16% |
| Casdin Capital, LLC | 127,500 | $8,670,000 | 2.11% |
| Prosight Management, LP | 40,000 | $2,720,000 | 2.00% |
| Camber Capital Management LP | 600,000 | $40,800,000 | 2.00% |